Author

Elodie Olivier

Centre National de la Recherche ScientifiqueORCID 0000-0002-6566-8170Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Fei YeiD· 1 shared Haofeng Hu· 1 shared Jean‐François GaucheriD· 1 shared Jia JiniD· 1 shared Lei WangiD· 1 shared Sylvain BroussyiD· 1 shared Xiaoqing YeiD· 1 shared Yilei He· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Fei YeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts

Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean‐François Gaucher, Lei Wang, Sylvain Broussy

This study evaluates a dimer peptide ligand of VEGF, D6, for inhibiting gastric cancer cell proliferation and xenograft growth, showing comparable efficacy to bevacizumab.

PLoS ONE · Aug 3, 2026Peer-reviewedPharmacology & Toxicology